The Mode of Inhibition of Mycobacterium tuberculosis Wild-Type and Isoniazid-Resistant 2-Trans-Enoyl-ACP(CoA) Reductase Enzymes by An Inorganic Complex

ISSN: 2211-3533 (Online)
ISSN: 2211-3525 (Print)


Volume 14, 2 Issues, 2016


Download PDF Flyer




Anti-Infective Agents

Formerly: Anti-Infective Agents in Medicinal Chemistry

This journal supports open access

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

View Full Editorial Board

Subscribe Purchase Articles Order Reprints


The Mode of Inhibition of Mycobacterium tuberculosis Wild-Type and Isoniazid-Resistant 2-Trans-Enoyl-ACP(CoA) Reductase Enzymes by An Inorganic Complex



Anti-Infective Agents, 7(1): 50-62.

Author(s): D. S. Santos, I. B. Vasconcelos, E. Meyer, F. A.M. Sales, I. S. Moreira and L A Basso.

Affiliation: Pontificia Universidade Catolica do Rio Grande do Sul, Centro de Pesquisas em Biologia Molecular e Funcional, Porto Alegre, RS, Brasil.

Abstract

Tuberculosis (TB) remains the leading cause of mortality due to a single bacterial pathogen, Mycobacterium tuberculosis. The reemergence of tuberculosis as a potential public health threat, the high susceptibility of human immunodeficiency virus-infected persons to the disease, the proliferation of multi-drug-resistant strains (MDR-TB) and, more recently, of extensively drug resistant isolates (XDR-TB) have created a need for the development of new antimycobacterial agents. There is an ongoing need for innovation in proposing new structural scaffolds for chemotherapeutic agent development to control TB. Mycolic acids, the hallmark of mycobacteria, are high-molecular-weight α-alkyl, β-hidroxy fatty acids, which appear mostly as bound esters in the mycobacterial envelope. Isoniazid (INH) is the most prescribed chemotherapeutic agent for active TB and prophylaxis and requires activation by the catalase-peroxidase activity of KatG. The product of the M. tuberculosis inhA structural gene (InhA) has been shown to be the primary target for INH. InhA was identified as an NADH-dependent enoyl-ACP reductase specific for long chain enoyl thioesters. InhA is a member of the mycobacterial Type II fatty acid biosynthesis system, which elongates acyl fatty acid precursors of mycolic acids. The main focus of our contribution is on data describing the mode of action of an inorganic complex, pentacyano (isoniazid) ferrateII that requires no KatG-activation and is an in vitro slow-onset inhibitor of WT and INH-resistant M. tuberculosis enoyl reductases. This inorganic complex represents a new class of lead compounds to the development of anti-tubercular agents aiming the inhibition of a validated target. We also describe the recent developments in the search for inorganic complexes with anti-tubercular activity.

Keywords:

Tuberculosis, mycolic acids, InhA, isoniazid, slow-onset inhibition, inorganic complex, drug resistance.



Download Free Order Reprints Order Eprints Rights and Permissions




Article Details

Volume: 7
Issue Number: 1
First Page: 50
Last Page: 62
Page Count: 13
DOI: 10.2174/187152108783329799
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science